COVID-19疫情期间的卒中管理:意大利伦巴第大区一家枢纽中心的挑战与结果
该研究回顾性分析了2020年3月1日至5月10日意大利伦巴第大区一家卒中中心收治的136例缺血性卒中患者,其中12例(9%)被评估为SARS-CoV-2感染高风险,5例(42%)接受了血管内治疗,无工作人员IgG检测阳性;与2019年同期相比,从首发症状到入院平均间隔延长(p < 0.05)。作者认为疫情期间血管内治疗面临多重挑战,院内特殊路径可兼顾操作安全与操作时间。
要点
- 疫情期间需行血管内治疗的卒中患者中,SARS-CoV-2感染高风险者占9%(12/136)。
- 所有影像学疑似COVID-19病例均经咽拭子确诊。
- 与2019年同期相比,从首发症状到入院平均间隔延长(p < 0.05)。
核心结论
- 疫情期间卒中的血管内治疗面临多重挑战。
- 院内可采用特殊路径以同时维持操作安全与操作时间。
研究设计与样本
- 回顾性分析2020年3月1日至5月10日一家意大利卒中中心需紧急神经介入治疗的卒中患者数据。
- 共纳入136例缺血性卒中患者,并与2019年3月1日至5月10日同一患者人群进行比较。
- 每例患者均接受鼻拭子聚合酶链反应检测、临床筛查和胸部CT扫描以评估SARS-CoV-2感染风险。
- 收集临床特征、人口学资料、临床病史及操作变量(door-to-needle时间、needle-to-mTiCi时间),并记录技术成功、操作安全性(含工作人员SARS-CoV-2感染)和出院时临床结局。
关键影像表现/征象
- 所有影像学疑似COVID-19病例均经咽拭子确诊。
诊断标准与关键数值
- 以鼻拭子聚合酶链反应检测、临床筛查和胸部CT扫描评估SARS-CoV-2感染风险,并将患者分类为「高风险」。
- 12例(9%)被归类为SARS-CoV-2感染「高风险」。
临床应用与阅片要点
- 本研究中心对每例患者行鼻拭子聚合酶链反应检测、临床筛查和胸部CT扫描以评估SARS-CoV-2感染风险。
- 本研究中心在院内采用特殊路径以维持操作安全与操作时间。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: We describe the reorganization carried out during the COVID-19 outbreak at one of the stroke centers in Italy and report on the clinical features and procedural variables of stroke patients in need of endovascular treatment.
METHODS: From 1 March to 10 May 2020, we retrospectively analyzed data from stroke patients in need of urgent neurointerventional treatment. Clinical presentation, demographics, and clinical history were collected along with procedural variables (door-to-needle time, needle-to-mTiCi time). Each patient underwent a nasal swab (polymerase chain reaction test), clinical screening, and chest CT scan to assess the risk of SARS-CoV-2 infection. Technical success, procedural safety (including staff SARS-CoV-2 infection), and clinical outcome at discharge were retrieved. A comparison was made with the same patient population treated between 1 March and 10 May 2019 to highlight possible differences in the characteristics or outcomes of the patients.
RESULTS: One hundred thirty-six ischemic stroke patients were admitted to our facility from 1 March to 10 May 2020. Of these, 12 patients (9%) were classified as "high risk" for SARS-CoV-2 infection. Radiological suspicion of COVID-19 was confirmed in all cases by pharyngeal swab. Five SARS-CoV-2 patients (42%) needed endovascular therapy. None of the staff members tested positive for IgG against SARS-CoV-2. Compared to the same period in 2019, an increase in the mean interval from the first symptoms to hospital arrival was observed (p < 0.05).
CONCLUSION: Endovascular treatment of stroke presented several challenges during the COVID-19 outbreak. Within the hospital, special pathways can be used to maintain both procedural safety and procedural times.
引用
- Asteggiano F, Divenuto I, Ajello D, et al. Stroke management during the COVID-19 outbreak: challenges and results of a hub-center in Lombardy, Italy. Neuroradiology. 2021. PMID: 33410950. doi:10.1007/s00234-020-02617-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。